Overview
Paradox Neurotechnologies develops minimally invasive spinal cord stimulation systems designed to treat chronic neuropathic pain with adaptive, closed-loop feedback.
More in Neuromodulation
Latest industry news
Flourish Emerges From Stealth With Bezos and Google Ventures Backing to Tackle Neuroscience
2026-10-26 · Funding
FDA Grants De Novo Approval to Modius Spero Neuromodulation Device for PTSD
2026-10-25 · Product
Wearable Neurofeedback Startup BRYM Secures €650K to Build Next-Generation Brain Training Platform
2026-10-24 · Funding
Brain-Computer Interface Gives Unresponsive ICU Patients Auditory Control for the First Time
2026-10-23 · Research
Company details
Category
⚡ Neuromodulation
Location
Minneapolis, MN
Funding
Series B — $42M
Website
paradoxneuro.comListed
2026-10-26
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →